On June 10, 2025, FDA Commissioner Martin A. Makary and Chief Medical and Science Officer Vinay Prasad published an article in the Journal of the American Medical Association titled, “Priorities for a New FDA.”1 The article...more
6/25/2025
/ Artificial Intelligence ,
Biosimilars ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Healthcare Reform ,
New Regulations ,
Popular ,
Prescription Drugs ,
Public Health ,
Regulatory Reform ,
Regulatory Requirements
Spurred by President Biden's call for action to increase drug competition and a 2021 letter addressed to the U.S. Patent and Trademark Office (USPTO) by Senators Leahy and Tillis requesting the USPTO "to take action to...more